Epigenomics AG NA buy matumba
Start price
30.01.11
/
50%
€8.49
Target price
01.08.11
€11.00
Performance (%)
-27.52%
End price
01.08.11
€6.15
Summary
This prediction ended on 01.08.11 with a price of €6.15. The price of Epigenomics AG NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.52%. matumba has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epigenomics AG NA | - | - | - | - |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% | 57.331% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% | 88.129% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% | 49.690% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% | 59.994% |
Comments by matumba for this prediction
In the thread Epigenomics AG NA diskutieren
einsteigen
ich tat mir anfangs schwer, halte aber die aktien seit längeren,
jetzt kaufe ich sogar nach:
Epigenomics künftiger CFO überzeugt genauso wie Epi ProColon 2.0
Mannheim (aktiencheck.de AG) - Thomas Schießle, Analyst von MIDAS Research,
stuft die Aktie von Epigenomics (ISIN DE000A0BVT96/ WKN A0BVT9) unverändert mit dem Rating "langfristig kaufen" ein. Das neu...
(Laufzeit überschritten)